MGMT and cancer: Our results are comparable to the degree of in vitro MGMT knockdown previously described with O6-BG and anti-MGMT siRNA encapsulated in cationic liposomes.51, 52 The dose of priming ionizing radiation needed for optimal delivery of AMONs appears to vary among different cancer cell types (Figures 1a, e and f).